Other Stories

S. Korea edges closer to 1 million COVID-19 vaccinations Updated: 2021-04-06 04:52:16 KST

Go see a doctor if the painkiller acetaminophen doesn't work in relieving fever, muscle pain or headache after being inoculated with a Covid vaccine.
That's the latest guideline by South Korea's health authorities with more than 962-thousand people vaccinated with their first shot - that's about one.eight-five percent of the nation's population - more than month into the country's Covid-19 vaccine rollout.

As of Monday, 32 suspected deaths linked to COVID-19 vaccines were reported in South Korea: of them officials have concluded that 19 were NOT linked to the vaccines, the results of two have yet been announced while 11 are still under investigation.

"After investigating five deaths, it's hard to confirm a definitive link to the vaccine. Based on data we've collected and analyzed, it's more likely they died from other causes, such as liver disease or heart failure. We've had three reports of suspected anaphylaxis. One was recognized as anaphylaxis, and other two were not."

Of the 109 suspected cases of post-vaccine anaphylaxis, only two were proven to have been connected to the shot.

Meanwhile, despite concerns of global shortage in vaccine supplies, President Moon Jae-in reaffirmed that the country is on track to meet its goal to vaccinate 12 million people in the first quarter and form herd immunity by November.

"We plan to make full use of the vaccines we've already secured and inoculate more people faster than planned. Since the first shot alone is confirmed to have a great effect in preventing infections, the government has decided to expand the number of primary vaccine receivers as much as possible and expedite the process."

To speed up the approval process, Seoul's drug safety ministry has simplified ways to import Covid-19 vaccines by waiving requirements for foreign drugmakers to present certificates from their countries.
Jang Tae-hyun, Arirang News.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.